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BRIEWE,
I would like to conclude with a testimony by G W H Tayler,
one of Maxwell's close colleagues: 'We, his contemporaries at
college, have seen in him high powers of mind and great
capacity and original views, conjoined with deep humility
before his God, reverent submission to His will, and hearty
belief in the love and atonement of that divine Saviour, who
was his portion and Comforter in trouble and sickness."
May many postmodern men and women rediscover and cast
themselves again on the hope that inspired James Clerk
Maxwell and many others.
F J Eksteen
Church of Scotland Hospital
Tugela Feiry
KwaZulu-Natal
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Dr St Clair Gibson replies: The author provides an
interesting viewpoint in his letter. As described previously, it is
impossible to prove or disprove the presence of a deity or
higher being, and in the best spirit of postmodemism, every
viewpoint is correct, but only to those individuals who believe
in their own particular viewpoint.
RECOMBINANT HUMAN ERYTHROPOIETIN IN
END-STAGE RENAL DISEASE
To the Editor: Provincial administrations in South Africa are
encouraged to promote cost-effective health care from meagre
health budgets stretched to the limit by highly prevalent
diseases such as tuberculosis and HIV/ AIDS. Although
therapy of such treatable conditions is truly warranted this
should not be at the cost of forgoing proven and cost-effective
therapies for other chronic illnesses, such as the anaemia of
end-stage renal disease. Anaemia has a major impact on the
quality of life of such patients where fatigue, reduced exercise
tolerance, dyspnoea, and cognitive, sexual and sleep
dysfunctions abound. Therapy of the anaemia of end-stage
renal disease using recombinant human erythropoietin (rhEPO)
and iron supplementation (ideally intravenously) has been
supported by substantial research evidence (level 1) and
effectively reverses or improves most of the aforementioned
symptoms. Furthermore there is increasing awareness that the
use of rhEPO in pre-end-stage renal disease slows progression,
improves co-morbidities and reduces hospital admissions (as it
does in end-stage patients). Such treated patients therefore
function better in their communities, are often able to continue
with employment and spend less time in hospital, to the
benefit of themselves and of course the administrative bodies.
Blood transfusion temporarily improves anaemia in such
patients although at the risk of viral and other infections,
allosensitisation, iron overload and a not insignificant cost. The
cost factor of such therapy is often forgotten when prescribing
blood transfusions and if lymphocyte-depleted packed cells are
used this can amount to over R900 per unit.
Unfortunately it is undeniable that rhEPO is also expensive
(and likely to remain so). This economic fact of life, coupled
with the aforementioned administrative concerns about
escalating health care costs, has allowed decisions regarding
the use of rhEPO to be made on political or economic grounds
rather than clinical need or expectation of benefit. Regrettably
in South African state hospitals renal replacement therapy
(dialysis and transplantation) is only available to a highly
selected few. Unfortunately these few are denied rhEPO (and
intravenous iron for that matter), which is in reality inadequate
therapy for their end-stage renal disease. However, rhEPO is
available to these indigent patients in some provinces (Gauteng
and the Free State) and not in others. This discrepancy is
unconstitutional and requires immediate and aggressive action
and correction from medical, political, and most importantly,
patient organisations.
As this expensive form of therapy may easily deplete even
the most generous of budgets it requires vigilant control,
prescription by adequately trained personnel, and aggressive
monitoring of clinical benefit and cost effectiveness. Ideally the
use of rhEPO should adhere to strict guidelines adequately
representing the South African perspective. Until such
guidelines are available international guidelines should suffice
(as detailed by the United States-based Dialysis Outcomes
Quality Initiative and the European Best Practice Guidelines).
I am of the opinion that if the prescription of rhEPO is
adequately guarded through an understanding betw'een
attending medical personnel and provincial administrators
then patients suffering from end-stage renal disease should
experience a dramatic improvement in their quality of life and
long-term survival together with a reduction in expense to the
provincial budgets charged with treating them.
Geoffrey Bilil
Tygerberg Academic Hospitai
WCape
ALCOHOL AND YOUR HEALTH
To the Editor: Much has been written in the Journal on the
health consequences of alcohol misuse. Articles have covered
topics such as the negative effect of alcohol use on iron
overload, coronary heart disease (CHD), cirrhosis of the liver,
chronic digestive disease, pancreatitis, brain damage, fetal
alcohol syndrome, and trauma.
Over the last decade there has been increasing discussion on
the positive health effects of moderate consumption of alcohol I
This debate has been largely absent in South Africa. A recently
published article in the South African Journal of Clinical Nutrition
entitled 'If you drink alcohol, drink sensibly" has addressed
this issue as part of the Food-Based Dietary Guidelines (FBDG).
The FBDG on alcohol recommend that South African alcohol
consumers should engage in 'low-risk' drinking, defined as no
more that four standard units of alcohol per day for men and
no more that two units for women, with at least two alcohol-
free days per week. A standard unit is defined as one 340 rnl
can of beer containing 12 g of alcohol, a 120 rnl glass of wine,
or a 2S rnl tot of spirits.3 However, people are not encouraged
to start drinking or to drink more to gain any claimed health
benefit. Various categories of persons are advised not to
consume alcohol: children, individuals who are not able to
restrict their drinking to moderate levels, pregnant women,
persons operating machinery, persons taking prescription
medicines, and persons with a genetic tendency to alcohol
dependence.
Regarding the protective effects of alcohol consumption for
CHD, benefits may occur for some older individuals (e.g. men
over 3S years and postmenopausal women'), with drinking
levels as low as one drink every 2 days.s However, these
benefits are replicable through other means such as ceasing to
smoke, eating a balanced low-fat diet, and taking aspirin."
Drinking to the point of intoxication, which is fairly common
among many drinkers in South Africa over weekends,' is likely
to negate any health benefits. For younger persons alcohol is
likely to have a net detrimental effect on mortality due to its
role in violence and other forms of injury.
Public health experts are now questioning the 20 standard
drinks for men and 10 for women as weekly 'low-risk'
maximums (set out above). New Canadian guidelines are 14
standard drinks (of 13.6 g alcohol) per week for men and nine
for women, with no more than two drinks per day." This is a
topic requiring further debate in this country.
CD HParry
Alcohol and Drug Abuse Research Group
Medical Research COl/ncil
Tygerberg
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COMPLETE CONGENITAL HEART BLOCK
DIAGNOSED IN LABOUR
To the Editor: Complete congenital heart block is a relatively
rare disorder (incidence 1:20 000 - 2S 000) almost always
associated with the presence of passively acquired auto-
antibodies, usually anti-Ro (SSA) and anti-La (SSB).l Several
therapeutic options, including maternal immunosuppression
and anti-arrhythmic drugs, are available if the diagnosis is
made antenatally. We recently successfully managed a vaginal
delivery in a patient with fetal heart block diagnosed during
labour.
The patient, 21 years old, gTavida 2, para 1, attended the
antenatal clinic for the first time at 33 weeks' gestation. She had
previously had an uncomplicated vaginal delivery at term. All
the routine antenatal laboratory tests were within normal
limits. She did not return for the scheduled follow-up visit, but
presented 3 weeks later at the midwife obstetric unit in active
labour. The attending midwife registered a fetal bradycardia on
auscultation and the patient was transferred to Tygerberg
Hospital.
After the patient was admitted·to the labour ward, an
internal scalp electrode was applied which showed a non-
reactive cardiotocogTam pattern with a constant heart rate of
SS/min. The fetus was immediately examined with ultrasound.
There were no obvious congenital abnormalities. The atria
contracted normally at 140/min on an adequate four-chamber
view of the heart, but the ventricular response rate was about
SS/min. To exclude fetal distress, a scalp pH was attempted
but the patient's cervix was fully dilated and she subsequently
delivered.
A male infant was born, weighing 2 794 g and with good
Apgar scores. An ECG tracing on the infant confirmed a
complete heart block with a pulse rate of SS/min. The post-
delivery course of both mother and baby was uncomplicated.
Tests for the anti-Ro and anti-La antibodies were positive in the
mother, with antinuclear antibodies negative. Both anti-Ro and
anti-La antibodies were present in the infant, with the
antinuclear factor positive with a titre of 320. The infant is still
well 1 year later and did not require a pacemaker.
Complete heart block renders traditional cardiotocogTaphic
monitoring useless. The available options to monitor fetal
wellbeing during labour are ultrasound and frequent scalp
blood gas analysis. This condition must always be part of the
differential diagnosis of a fetal bradycardia on
cardiotocography tracing and demonstrates that a good
outcome is possible even in the absence of sophisticated and
expensive antenatal and intrapartum care.
Igno Siebert
Stefan Gebhardt
Department of Obstetrics and Gynaecology
University of Stellenbosch and
Tygerberg Hospital
Tygerberg, W Cape
1. Olah KS, Gee H. Fetal heart block associated \vith maternal anti-Ra (S5-A) antibody -
current management. A review. Br JObstt't GYllQl!coll991; 98: 751·755.
CME AND RECERTIFICATION
To the Editor: All who are currently registered with the Health
Professions Council of South Africa need to submit evidence of
having participated in continuing medical education,
designated as CPD points. This is also applicable to those who
practise outside the boundaries of South Africa and continue to
maintain registration in this country.
Continuing medical education is important and takes many
forms, including conference attendance, participation in
teaching activities, journal clubs and above all the self-
discipline of regularly reading the medical literature, such as
the SAMJ. As members of the medical profession, we have a
duty to remain abreast of recent advances. This is not easy in a
fast and changing world. Some doctors remain reluctant to
attend meetings or conferences, usually using the age-old
excuse of being too busy, or asking 'what are they going to
teach me?' There is a burden on both the individual and the
organisers of conferences; individuals must be motivated and
desire to improve their knowledge, while on the other hand the
organisers must put together attractive and balanced
programmes, with good and knowledgeable speakers.
Registrant involvement at conferences is desirable, as is the
opportunity to be kept abreast of regulatory changes. In an
ideal world all mesh, with satisfaction all around. Our patients
are the ultimate beneficiaries and we get our CPD points!
The controversial question of recertification remains a very
touchy issue with doctors, and in the USA it has been required
by most, if not all, specialties. A colleague of mine was
travelling by air in the US, and the person sitting next to him
was a uniformed airline pilot going for his annual
recertification. During their discussion, he mentioned that most
of the pilots pass their recertification examinations on the first
go. My colleague was appalled by the high pass rate and felt
that this was a sham. After further explanation, my colleague
realised that the purpose of pilot recertification was to ensure
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that pilots maintained essential skills and judgement.!
We all expect the pilots who fly us around the world to pass
their recertification examination. Shouldn't we expect the same
from all our doctors?
In 1993, I passed the recertification examination set by the
American Board of Anesthesiology.
Jan D Smith
IsMeTT-UPMC Italy
Palermo
Italy
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MRC Gold and Silver Medal
Awards
Nominations are hereby requested for the MRC Gold and
Silver Medal Awards. Nominations must be received by 30
August 2002 and should include a motivation and full CV,
indicating other awards and full publication record of the
nominated person.
GOLD MEDALS
Gold Medals may be awarded to persons who are or were
connected to the MRC in a full- or part-time capacity and who
made meritorious contributions to enhancing the prestige
of the MRC and/or extending medical knowledge. Only one
Gold Medal is usually awarded in a cycle of 2 years. -
Further criteria for awarding Gold Medals are:
* If an individual has made an exceptional breakthrough or
contribution in research that is acknowledged at national
and international level.
* If an individual has made a sustained contribution that has
received international acknowledgement for at least 15
years.
SILVER MEDALS
Silver Medals are awarded for excellence in terms of the
following criteria:
* For sustained research and international acknowledgment
over a period of at least 10 years.
* Where the individual has demonstrated leadership in the
field of research management and capacity development.
A Merit Awards Committee appointed by the Board will
consider these nominations in due course.
Queries and nominations to:
Ms Leverne Gething
Division Manager: News, Publications and Media
Relations
Medical Research Council
PO Box 19070
Tygerberg, 7550
Tel. (021) 938-0293
Fax (021) 938-0395
